{"url_path":"/sec/skye/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","accession_number":"0001628280-26-033417","cik":"0001516551","ticker":"SKYE","issuer_name":"Skye Bioscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","primary_entity_key":"0001516551","primary_entity_name":"Skye Bioscience, Inc."},"word_count":347,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\n3.1\n[Amended and Restated Articles of Incorporation of Registrant (incorporated by reference to Exhibit 3.1 to](https://www.sec.gov/Archives/edgar/data/1516551/000151655124000048/skye-ararticlesofincorpora.htm)[our](https://www.sec.gov/Archives/edgar/data/1516551/000151655124000048/skye-ararticlesofincorpora.htm)[Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on March 22, 2024)](https://www.sec.gov/Archives/edgar/data/1516551/000151655124000048/skye-ararticlesofincorpora.htm)\n\n3.2\n[Amended and Restated Bylaws of Registrant (incorporated by reference to Exhibit 3.2 to](https://www.sec.gov/Archives/edgar/data/0001516551/000164033421000483/skye_ex32.htm)[our](https://www.sec.gov/Archives/edgar/data/0001516551/000164033421000483/skye_ex32.htm)[Annual Report on Form 10-K for the year ended December 31, 2020 filed on March 2, 2021)](https://www.sec.gov/Archives/edgar/data/0001516551/000164033421000483/skye_ex32.htm)\n\n10.1\n[Master Services Agreement, dated March 31, 2026, by and between Skye Bioscience, Inc. and Lohman & Associates, Inc.](https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/ex101-260331_agmtxlohmanxm.htm)[(incorporated by reference to](https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/ex101-260331_agmtxlohmanxm.htm)[Exhibit 10.1 to](https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/ex101-260331_agmtxlohmanxm.htm)[our](https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/ex101-260331_agmtxlohmanxm.htm)[Current Report on Form 8-K filed with the SEC on April 3, 2026)](https://www.sec.gov/Archives/edgar/data/1516551/000162828026023699/ex101-260331_agmtxlohmanxm.htm)\n\n31.1#\n\n[Certification of Principal Executive Officer, pursuant to Rule 13a-14 and 15d-14 of the Securities Exchange Act of 1934](skye-20260331xex311xsectio.htm)\n\n31.2#\n\n[Certification of Principal Financial Officer, pursuant to Rule 13a-14 and 15d-14 of the Securities Exchange Act of 1934](skye-20260331xex312xsectio.htm)\n\n32.1#\n\n[Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](skye-20260331xex321xsectio.htm)\n\n32.2#\n\n[Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](skye-20260331xex322xsectio.htm)\n\n101#\n\nThe following materials from the Skye Biosciences, Inc. Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Balance Sheets (Unaudited), (ii) Condensed Consolidated Statements of Operations (Unaudited), (iii) Condensed Consolidated Statements of Cash Flows (Unaudited), (iv) Condensed Consolidated Statements of Stockholders’ Deficit (Unaudited), and (v) related Notes to the Unaudited Condensed Consolidated Financial Statements.\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\n_________\n\n# Filed Herewith\n\n27\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\nSkye Bioscience, Inc.,\na Nevada corporation\n\nMay 11, 2026By:/s/ Punit Dhillon\n\nPunit Dhillon\n\nIts:Chief Executive Officer, President, Secretary and Director\n(Principal Executive Officer)\n\nMay 11, 2026By:\n/s/ John P. Sharp\n\nJohn P. Sharp\n\nIts:Chief Financial Officer\n(Principal Financial and Accounting Officer)\n\n28"}